All In Biotech

Drug Trial Radar · NCT02163902

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

A Multicenter, Double-blind, Nontreatment, Long-term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area

Last checked: Nov 19, 2026Latest source record: Feb 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

224

Actual

Start

Dec 2013

Primary completion

Jan 2016

Study completion Aug 2016

Sponsor

Lead sponsor
Kythera BiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jun 16, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Other
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat.

Conditions

  • Submental Fat
  • Healthy

Interventions

  • ATX-101Drug

    Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements, recording of adverse events

  • PlaceboDrug

    Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements, recording of adverse events

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Maintaining CR-SMFRS 1-Grade Response During 3 Years of Follow up, i.e. % of Participants Who Were CR-SMFRS 1-Grade Responders at Both Long-term LTFU Baseline and at Subsequent LTFU VisitsTime frame: From 12 weeks after last treatment (in the predecessor study) to up to 36 months after last treatment

Locations

15 sites in 2 countries. Site status is shown where the registry gives one.

  • Dermatology Cosmetic Laser Medical Associates of La Jolla

    San Diego, California

  • AboutSkin Dermatology and DermSurgery, PC

    Englewood, Colorado

  • Dermatology Research Institute

    Coral Gables, Florida

  • Stephan Baker MD PA

    Coral Gables, Florida

  • Baumann Cosmetic and Research Center

    Miami, Florida

  • Kenneth R. Beer, MD, PA

    West Palm Beach, Florida

  • Altman Dermatology Associates

    Arlington Hts, Illinois

  • DeNova Research

    Chicago, Illinois

  • DuPage Medical Group, Dermatology Institute

    Naperville, Illinois

  • Callender Center for Clinical Research

    Glendale, Maryland

  • Aesthetics, Skin Care, Dermatologic Surgery

    Rockville, Maryland

  • Tennessee Clinical Research Center

    Nashville, Tennessee

  • Research Across America

    Plano, Texas

  • Shannon Humphrey, MD

    Vancouver, Canada

  • Carruthers Dermatology Centre Inc.

    Vancouver, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.